The Unified Patent Court (‘UPC’) opened its doors on 1 June 2023. It is a new court in the European Union (‘EU’). It provides a forum for litigating patents granted by the European Patent Office (‘EPO’) that have been validated as either:
A claimant at the UPC has the power to enforce their UPs or EPs in all the contracting states where infringement is occurring (and, for EPs, where they are also validated), instead of having to bring separate patent infringement actions in each such country. There are currently 17 contracting states, including key patent jurisdictions such as Germany, France, The Netherlands, and Italy. A further 7 EU countries may join the UPC once they ratify the UPC Agreement (‘UPCA’). Spain, Poland and Croatia have decided not to join the system. Also, key EP countries outside the EU, such as the United Kingdom and Switzerland, cannot join. Thus, parallel litigation in multiple European countries will still be necessary in some cases.
In a similar vein, a defendant at the UPC will have the power to seek “central” revocation of a UP or EP, that is to say, to have the patent revoked in all the contracting states by one action, rather than through a number of separate revocation actions via national procedures. Note that an earlier unsuccessful EPO opposition does not estop this right to seek central revocation later.
For those interested in bringing an action at the UPC, and of course for those defending against such actions, there is one really key feature of the court to be aware of: it is incredibly front loaded, especially in comparison to proceedings in the US, the UK and other common law jurisdictions, and the bulk of the case has to be set out in writing. The oral hearing will not be an opportunity to argue your case, and cross-examination the other side’s case is likely to be very limited. The hearing is likely to be inquisitorial, that is, led by the judges to clarify points in the written submissions of the parties.
The claimant, therefore, has to prepare their entire action up front, which is not just their pleadings, but also the facts relied, all known evidence (although they can request access to further evidence but not disclosure per se) and their legal arguments. Obviously, this will also front-end most of the legal costs. Critically, however, because they control when they file their action the claimant has time – time to prepare their action and also time to prepare for any likely counterclaim. A defendant on the other hand, only has 3 months from the date of being served with the action (and there is no requirement to undertake pre-action correspondence with the other side) to:
The defence to counterclaims, replies and responses that follow from the initial pleadings all allow the receiving party less time to respond, going from 3 months to 2 months and then 1 month.
You will appreciate, therefore, that in a court with such tight deadlines, front-loaded submissions, and a focus on the written submissions, plus an aim to complete all actions filed within a year or so, that being subject to an action without any prior preparation will potentially be very disadvantageous.
Accordingly:
The UPC is still very new. There have been just over 50 cases filed since June. Parties that are well-prepared, including for the counter-punch, are likely to benefit from a strong advantage in any actions at the court. Some effort now, could pay dividends in the future. If you would like to discuss any of the above, please reach out to your usual Mewburn Ellis contact or to Dr Sean Jauss, head of our legal services department.
The Unitary Patent and the Unified Patent Court - A guideFind out more about the Unitary Patent and Unified Patent Court with our detailed guide. This covers a summary overview of both as well as details around costs and processes to obtain a unitary patent and a comparison of pros and cons. |
Sean is a European IP lawyer. He is head of our legal services team and a member of our Management Board. He has over 20 years of experience advising on contentious and non-contentious IP matters, including patents, trade marks, designs, copyright, database rights and trade secrets. He has a particular focus on the life science, bioinformatics, pharma and advanced materials sectors. Sean works closely with senior management and their external advisors to deliver a wide range of IP related projects in a pragmatic and commercially-focussed manner, including on IP protection, commercialisation, technology transfer and litigation.
Email: sean.jauss@mewburn.com
Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.
Our peopleWe have an easily-accessible office in central London, as well as a number of regional offices throughout the UK and an office in Munich, Germany. We’d love to hear from you, so please get in touch.
Get in touch